| Literature DB >> 35629673 |
Anna Górska1, Marcel Zambrzycki1, Beata Paczosa-Bator1, Robert Piech1.
Abstract
A new electrochemical sensor based on hierarchical carbon nanofibers with Ni and Co nanoparticles (eCNF/CNT/NiCo-GCE) was developed. The presented sensor may be characterized by high sensitivity, good electrical conductivity, and electrocatalytic properties. Reproducibility of its preparation expressed as %RSD (relative standard deviation) was equal to 9.7% (n = 5). The repeatability of the signal register on eCNF/CNT/NiCo-GCE was equal to 3.4% (n = 9). The developed sensor was applied in the determination of the antihistamine drug-cetirizine hydrochloride (CTZ). Measurement conditions, such as DPV (differential pulse voltammetry) parameters, supporting electrolyte composition and concentration were optimized. CTZ exhibits a linear response in three concentration ranges: 0.05-6 µM (r = 0.988); 7-32 (r = 0.992); and 42-112 (r = 0.999). Based on the calibration performed, the limit of detection (LOD) and limit of quantification (LOQ) were calculated and were equal to 14 nM and 42 nM, respectively. The applicability of the optimized method for the determination of CTZ was proven by analysis of its concentration in real samples, such as pharmaceutical products and body fluids (urine and plasma). The results were satisfactory and the calculated recoveries (97-115%) suggest that the method may be considered accurate. The obtained results proved that the developed sensor and optimized method may be used in routine laboratory practice.Entities:
Keywords: carbon nanofibers; carbon nanotubes; cetirizine; glassy carbon electrode; metal nanoparticles; voltammetry
Year: 2022 PMID: 35629673 PMCID: PMC9147852 DOI: 10.3390/ma15103648
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.748
Figure 1SEM (A,B) and BFTEM (C) images of hierarchical nanofibers—eCNF/CNT/NiCo. (D) HRTEM close-up of MWCNT.
Figure 2(A) GIXRD diffraction pattern and (B) Raman spectra of hierarchical nanofibers, eCNF/CNT/NiCo.
Figure 3Dependence of the volume of applied surface modifier on the CTZ signal. Experiment conducted in 0.1 M phosphate buffer, CTZ concentration was equal to 10 µM. (A) DPV voltammograms, (B) graph.
Figure 4CV LSV measurement of 100 µM of CTZ in 0.1 M phosphate buffer. Scan rate values were in the range of 6.3 mV s−1 to 500 mV s−1. Dependence of CTZ peak current on scan rate (inset).
Figure 5Dependence of pH of phosphate buffer (0.1 M) on CTZ peak potential.
Figure 6Proposed mechanism of CTZ electrode reaction [18].
Figure 7(A) CTZ calibrations with 2 linear ranges: 0.05–6 µM; 7–32 µM. (B) Voltammograms registered during calibration.
Comparison of LOD values for CTZ obtained using voltammetric methods.
| Type of WE | LOD, nM | Reference |
|---|---|---|
| CPE-MWCNTs-Pt | 58.6 | [ |
| PLMCNTPE | 170 | [ |
| Bent/CPE | 59.1 | [ |
| CTABMCNTPE | 270 | [ |
| RuTiO2-MWCNTs | 3.1 | [ |
| MWCNT-GCE | 70.7 | [ |
| chitosan/IL/MWCNTs/GCE | 8 | [ |
| BiF-GCE | 1.5 | [ |
| GCE | 4500 | [ |
| GPE | 160 | [ |
| BDDE | 16 | [ |
| eCNF/CNT/NiCo-GCE | 14 | This work |
CPE-MWCNTs-Pt—carbon paste electrode modified with multi-walled carbon nanotubes and Pt nanoparticles; PL CNTPE—poly(L-Leu) modified carbon nanotube paste electrode; Bent/CPE—carbon paste electrode with layered structured bentonite clay; CTABMCNTPE—cetyl trimethylammonium bromide modified carbon nanotube paste electrode; RuTiO2-MWCNTs-CPE—ruthenium-doped titanium dioxide nanoparticles and multi-walled carbon nanotubes modified carbon paste electrode; MWCNT-GCE—multi-walled carbon nanotubes modified glassy carbon electrode; chitosan/IL/MWCNTs/GCE—chitosan, ionic liquid and multi-walled carbon nanotubes modified glassy carbon electrode; BiF-GCE—bismuth film glassy carbon electrode; GPE—graphite pencil electrode; BDDE—boron doped diamond electrode.
Results of sample measurements: tablets and urine.
| Sample | CTZ Added, mg | CTZ Found ± s, mg |
|---|---|---|
| Allertec WZF a | 0 | 10.9 ± 0.7 |
| 10 | 25.0 ± 0.9 (108) | |
| 20 | 34 ± 3 (100) | |
| Cirrus Duo b | 0 | 5.5 ± 0.2 |
| 5 | 12.9 ± 0.1 (109) | |
| 10 | 17.3 ± 0.6 (110) | |
| Sample | CTZ added ± s, µM | CTZ found ± s, µM (recovery, %) |
| Urine diluted 40× | 0 | ND |
| 1 | 1.1 ± 0.1 (108) | |
| 2 | 2.3 ± 0.3 (110) | |
| Urine diluted 10× | 0 | ND |
| 3 | 3.1 ± 0.2 (103) | |
| 6 | 6.9 ± 0.5 (110) | |
| Plasma diluted 125× | 0 | ND |
| 1 | 1.2 ± 0.1 (115) | |
| 2 | 2.3 ± 0.3 (113) | |
| Plasma diluted 35× | 0 | ND |
| 3 | 3.3 ± 0.2 (109) | |
| 6 | 5.8 ± 0.5 (97) |
ND—not detected; a producer declares 10 mg of CTZ in tablet; b producer declares 5 mg of CTZ in tablet.